Study Comparing Treatment With Alluzience vs Reconstituted Toxin
Clinical trial NCT05277337 · COMPLETED
Trial details
- NCT number
- NCT05277337
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-04
- Primary completion
- 2022-10-12
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.